Medico Intercontinental Limited (BOM:539938)

Medico Intercontinental Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	820.35	960.15	713.55	762.26	742.6	697.41
Other Revenue	2.61	2.61	1.52	2.96	1.2	0.29
Revenue	822.95	962.76	715.07	765.22	743.8	697.7
Revenue Growth (YoY)	-3.83%	34.64%	-6.55%	2.88%	6.61%	-14.93%
Cost of Revenue	638.83	746.15	548.77	623.13	608.51	576.26
Gross Profit	184.12	216.61	166.3	142.09	135.29	121.43
Selling, General & Admin	85.8	64.47	64.21	43.67	44.47	39.02
Other Operating Expenses	49.71	64.37	39.91	40.69	37.51	32.81
Operating Expenses	166.48	136.9	106.97	86.37	83.99	73.16
Operating Income	17.65	79.71	59.34	55.72	51.3	48.28
Interest Expense	-49.23	-9.67	-4.8	-6.11	-8.65	-12.67
Other Non Operating Income (Expenses)	-0.28	-0.28	-0.13	-0.08	-0.09	-0.12
EBT Excluding Unusual Items	-31.67	69.75	54.41	49.53	42.56	35.48
Impairment of Goodwill	-0.02	-0.02	-0.02	-0.03	-0.04	-0.05
Pretax Income	-31.69	69.73	54.39	49.5	42.53	35.43
Income Tax Expense	14.84	19.16	14.91	13.42	11.53	9.67
Net Income	0.12	50.57	39.47	36.08	31	25.76
Net Income to Common	0.12	50.57	39.47	36.08	31	25.76
Net Income Growth	-99.75%	28.13%	9.39%	16.41%	20.32%	9.31%
Shares Outstanding (Basic)	10	10	10	6	3	3
Shares Outstanding (Diluted)	10	10	10	6	3	3
Shares Change (YoY)	0.24%	-	55.51%	97.92%	-	-
EPS (Basic)	0.01	5.06	3.95	5.61	9.54	7.93
EPS (Diluted)	0.01	5.06	3.95	5.61	9.54	7.93
EPS Growth	-99.75%	28.13%	-29.66%	-41.19%	20.32%	9.31%
Free Cash Flow	55.37	-91.14	43.42	-105.25	36.38	56.09
Free Cash Flow Per Share	5.53	-9.11	4.34	-16.37	11.20	17.27
Dividend Per Share	-	-	-	0.100	-	-
Gross Margin	22.37%	22.50%	23.26%	18.57%	18.19%	17.41%
Operating Margin	2.14%	8.28%	8.30%	7.28%	6.90%	6.92%
Profit Margin	0.01%	5.25%	5.52%	4.71%	4.17%	3.69%
Free Cash Flow Margin	6.73%	-9.47%	6.07%	-13.75%	4.89%	8.04%
EBITDA	48.62	87.78	62.18	57.72	53.32	49.61
EBITDA Margin	5.91%	9.12%	8.70%	7.54%	7.17%	7.11%
D&A For EBITDA	30.97	8.07	2.85	2.01	2.02	1.33
EBIT	17.65	79.71	59.34	55.72	51.3	48.28
EBIT Margin	2.14%	8.28%	8.30%	7.28%	6.90%	6.92%
Effective Tax Rate	-	27.48%	27.42%	27.11%	27.11%	27.29%
Revenue as Reported	830.35	963.71	717.57	767.38	745.66	699.19
Advertising Expenses	-	12.94	21.33	7.7	17.74	13.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.